Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 2:31 AM
Study NCT ID:
NCT07347951
Status:
RECRUITING
Last Update Posted:
2026-01-16
First Post:
2025-12-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
Sponsor:
First Affiliated Hospital of Wenzhou Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-26
First Submit QC Date:
None
Study First Post Date:
2026-01-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-11
Last Update Post Date:
2026-01-16
Last Update Post Date Type:
ACTUAL